Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Non-Current Deferred Tax Liability: 2020-2024

Historic Non-Current Deferred Tax Liability for Caribou Biosciences (CRBU) over the last 5 years, with Dec 2024 value amounting to $548,000.

  • Caribou Biosciences' Non-Current Deferred Tax Liability fell 1.62% to $548,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $548,000, marking a year-over-year decrease of 1.62%. This contributed to the annual value of $548,000 for FY2024, which is 94.12% down from last year.
  • According to the latest figures from FY2024, Caribou Biosciences' Non-Current Deferred Tax Liability is $548,000, which was down 94.12% from $9.3 million recorded in FY2023.
  • Caribou Biosciences' Non-Current Deferred Tax Liability's 5-year high stood at $10.9 million during FY2022, with a 5-year trough of $155,000 in FY2020.
  • For the 3-year period, Caribou Biosciences' Non-Current Deferred Tax Liability averaged around $6.9 million, with its median value being $9.3 million (2023).
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first surged by 2,043.87% in 2021, then plummeted by 94.12% in 2024.
  • Over the past 5 years, Caribou Biosciences' Non-Current Deferred Tax Liability (Yearly) stood at $155,000 in 2020, then surged by 2,043.87% to $3.3 million in 2021, then surged by 227.54% to $10.9 million in 2022, then decreased by 14.41% to $9.3 million in 2023, then crashed by 94.12% to $548,000 in 2024.